Euromed Pharma signed up as a member of Pharma.Aero’s Life Sciences Manufacturers Advisory Platform, becoming LMAP’s 10th pharmaceutical manufacturer. With the latest additions, Pharma.Aero consolidates its position as a hub for industry collaboration and innovation.

Euromed Pharma’s extensive expertise in Advanced Therapy Medicinal Products (ATMP) clinical trials and product market access enriches the collective knowledge base of the Life Sciences Manufacturers Advisory Platform.

Frank Van Gelder, Secretary General of Pharma.Aero, welcomes Euromed Pharma to the global community: “We are excited to welcome Euromed Pharma to our platform, and look forward to leveraging their insights and contributions to drive positive change and accelerate the delivery of life-saving therapies around the globe.

By signing up for the LMAP, Euromed Pharma joins a select group of industry leaders within the Life Sciences Manufacturers Advisory Platform: MSD, Pfizer, Zoetis, Novartis, Johnson & Johnson, Bayer, Astra Zeneca’s Alexion, GSK and Germinare.

Pharma.Aero created the Life Science Manufacturers Advisory Platform (LMAP) to further engage the manufacturing segment to provide first-line advice on the activities and projects of Pharma.Aero and support the logistics and supply chain industry. The LMAP integrates into all Pharma.Aero cross-industry initiatives and provide content value to the organization.